Institute for Interdisciplinary

Innovation in healthcare

Program in Healthcare Innovation

Registrations for the 2021 edition are now open!
3h
3h

Toward COVID-19 vaccine development

In the interview given to BX1, our co-director, Michel Goldman, talks about the progress made in the fight against COVID-19, the unprecedented acceleration of the research process and possible issues with the production of sufficient quantities of the vaccine.

How to prevent and cure COVID-19?

Watch the recording of our conference-debate on the vaccines and immunotherapies at the forefront of the fight against the pandemic.

I3h Publications

The Case for COVID-19 Antibody Therapies

Given the limitations of existing drugs and the uncertainty regarding vaccines, the world must also focus on developing new weapons to target the SARS-CoV-2 virus that causes COVID-19. Besides anti-viral chemical drugs, genetically engineered antibodies might be ideal for this purpose.

Read the article published in Project Syndicate by Michel Kazatchkine and our co-director, Michel Goldman, where they call for more funds to be allocated towards the research on antibody treatments.